Public Health England have released a November 2016 update to their assessment of rates of, amongst others, HIV, hepatitis B and C in people who inject drugs in the UK.
As NPS have entered the markets at an unprecedented rate, legislation has been unable to keep pace. This report for policymakers and legal practioners, from the EMCDDA and Eurojust, aims to outline the challenges and paths forward in NPS regulation.
Prison reform under the MAS government confronts serious hurdles but has demonstrated a commitment to confront institutional problems in the judiciary, police, and prison systems through varied initiatives.
Drug and Alcohol Findings argues that evidence is stacked in favour of drug consumption rooms as an effective strategy for tackling public injecting and the harms associated with it.
A look at the implementation of Uruguay’s law so far reveals some apparent early obstacles that policymakers should consider if the measure is to achieve its intended aims.
The Council on International Relations of Latin America and the Caribbean (RIAL) analyses the lessons of the UNGASS for Latin America and advances strategies which would catalyse innovation in drug policy in the region.
MENHARA has released a guide for MENA countries to include a gender perspective and promote equality and human rights for women and girls in their harm reduction programs.
A paper by the Global Drug Policy Observatory argues that whereas Clinton advanced a an ambitious, progressive strategy with some question marks, Trump's position is a sparse collection of misguided ideas.
Transform release the second edition of their guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world.
